Baxter International Inc. vs Pfizer, Inc. — Stock Comparison

BAX
Baxter International Inc.
$17.21
▼ 2.10%
vs
PFE
Pfizer, Inc.
$26.33
▼ 1.39%
Q·Score Winner
Pfizer, Inc.
PFE6.5/10vs 4.8/10

Q·Score Breakdown

4.8
Bearish
Overall
6.5
Neutral
3.8
Quality
7.4
4.5
Health
7
4.7
Growth
5.6
7.1
Valuation
6.7
4
Sentiment
5.2
BAX

Consensus analyst target of $22.12 is 29% above current price.

currently unprofitable (-10% margin).

PFE

Strong profitability with 12% net profit margins.

analyst sentiment is cautious.

Analyst Consensus

HOLD
Target $22.12 (+28.5%)
13 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts

Fundamentals

BAX
PFE
Trailing P/E
19.4×
8.5×
Forward P/E
9.4×
-9.7%
Profit Margin
12.4%
34.6%
Gross Margin
75.8%
ROE
8.9%
2.9%
Revenue Growth
-1.2%
Earnings Growth
0.62
Beta
0.39
Price / Book
$8.9B
Market Cap
$149.8B
$16 – $33
52-Week Range
$22 – $29

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →